Erlotinib hydrochloride and Thrombocyte count - from FDA reports
Thrombocyte count is reported only by a few people who take Erlotinib Hydrochloride. We study 4,447 people who have side effects while taking Erlotinib hydrochloride from FDA. Among them, 1 have Thrombocyte count. Find out below who they are, when they have Thrombocyte count and more.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Jul, 17, 2017
4,447 people reported to have side effects when taking Erlotinib hydrochloride.
Among them, 1 person (0.02%) has Thrombocyte count
Number of reports submitted per year:
Time on Erlotinib hydrochloride when people have Thrombocyte count *:
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Thrombocyte count when taking Erlotinib hydrochloride *:
- female: 100 %
- male: 0.0 %
Age of people who have Thrombocyte count when taking Erlotinib hydrochloride *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Top conditions involved for these people *:
- Pancreatic Carcinoma (1 person, 100.00%)
Top co-used drugs for these people *:
- Gemcitabine (1 person, 100.00%)
Top other side effects for these people *:
- Malignant Neoplasm Progression (1 person, 100.00%)
- Hypoalbuminaemia (1 person, 100.00%)
- Hepatic Failure (1 person, 100.00%)
- Fever (1 person, 100.00%)
- Fatigue (1 person, 100.00%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Thrombocyte count when taking Erlotinib hydrochloride?
Erlotinib hydrochloride has active ingredients of erlotinib hydrochloride. (latest outcomes from Erlotinib hydrochloride 4,459 users)
Thrombocyte count has been reported by people with high blood pressure, lung cancer - non-small cell, insomnia, breast cancer female, gastritis (latest reports from 172 Thrombocyte count patients).